--- title: "DEZHAN HEALTHCARE: The relevant experiments for the IND application of WYY injection for stroke indications have been basically completed, and the clinical trial application is expected to be submitted in the second half of the year" type: "News" locale: "en" url: "https://longbridge.com/en/news/259236105.md" description: "36Kr learned that DEZHAN HEALTHCARE stated on the interactive platform that the relevant experiments for the IND application of WYY injection for stroke indications have been basically completed, and the clinical trial application is expected to be submitted in the second half of the year" datetime: "2025-09-29T01:06:29.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/259236105.md) - [en](https://longbridge.com/en/news/259236105.md) - [zh-HK](https://longbridge.com/zh-HK/news/259236105.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/259236105.md) | [繁體中文](https://longbridge.com/zh-HK/news/259236105.md) # DEZHAN HEALTHCARE: The relevant experiments for the IND application of WYY injection for stroke indications have been basically completed, and the clinical trial application is expected to be submitted in the second half of the year 36Kr learned that DEZHAN HEALTHCARE stated on the interactive platform that the relevant experiments for the IND application of WYY injection for stroke indications have been basically completed, and the clinical trial application is expected to be submitted in the second half of the year ### Related Stocks - [DEZHAN HEALTHCARE (000813.CN)](https://longbridge.com/en/quote/000813.CN.md) ## Related News & Research - [Charlie Munger's 2008 Investment Into This Company Made 39x Returns Over 17 Years, But Berkshire's Timely Exit May Have Cemented The Profits](https://longbridge.com/en/news/277606465.md) - [Aspen Pharmacare aims for Canada entry with Ozempic generic by third quarter](https://longbridge.com/en/news/277631988.md) - [Asia high-sulphur fuel oil crack to Dubai flips into premium as Mideast tensions expected to tighten exports](https://longbridge.com/en/news/277432401.md) - [08:03 ETDecentralized Clinical Trial Validates Novel "Fasting Mimetic" Formulation for Cardiometabolic Health](https://longbridge.com/en/news/277468910.md) - [Jardine Matheson (LON:JAR) Hits New 12-Month High - Time to Buy?](https://longbridge.com/en/news/277302204.md)